109196 ⎘
Structure or type of the nucleic acid; Chemical structure; Nature of the modification; Conjugate Lipophilic moiety, e.g. cholesterol
GNAQ targeted dsRNA compositions and methods for inhibiting expression
#302TARGETING RLIM TO MODULATE BODY WEIGHT AND OBESITY
#303TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES
#304NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#305Targeting technology to selectively express mRNAs in cardiomyocytes while avoiding stimulation of cardiac fibroblasts
#306DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM
#307DOUBLE-STRANDED NUCLEIC ACID COMPLEX AND USE THEREOF
#308Oligonucleotide compositions and methods of making the same
#309SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#310COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
#311RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA)
#312COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#313OLIGONUCLEOTIDE COMPOUNDS FOR TARGETING HUNTINGTIN MRNA
#314NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF PROS1 IN A CELL
#315Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
#316Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing
#317RNAi Inhibition of Alpha-ENaC Expression
#318Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#319NUCLEIC ACID CARRIER AND METHOD FOR ADMINISTERING NUCLEIC ACID
#320Carboxypeptidase B2 (CPB2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#321COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
#322Oversubscription scheduling
#323METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1
#324DIRECT OLIGONUCLEOTIDE SYNTHESIS ON CELLS AND BIOMOLECULES
#325AIM2 INHIBITORS AND USES THEREOF
#326COMPOSITIONS FOR DELIVERY OF CODON-OPTIMIZED MRNA
#327SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT
#328TARGETS AND METHODS FOR TREATING EPSTEIN-BARR VIRUS MEDIATED NEURODEGENERATION
#329A DBAIT MOLECULE IN COMBINATION WITH KINASE INHIBITOR FOR THE TREATMENT OF CANCER
#330Compositions and methods of treating muscle atrophy and myotonic dystrophy
#331KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#332TREATMENT OF CNS INJURY WITH RNAi THERAPEUTICS
#333CORONAVIRUS IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#334P-ethoxy nucleic acids for STAT3 inhibition
#335EXTRAHEPATIC DELIVERY
#336ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#337PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#338RNAi Inhibition of Alpha-ENaC Expression
#339Methods for Oral Delivery of Oligonucleotides
#340HNF4a saRNA compositions and methods of use
#341RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS
#342Compounds and Methods for Use in Dystrophin Transcript
#343RNAi agents for Hepatitis B virus infection
#344Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#345Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#346Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#347Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#348Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#349Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#350COMPOUNDS AND METHODS FOR MODULATION OF SMN2
#351Compositions and methods of treating muscle atrophy and myotonic dystrophy
#352IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE
#353COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES
#354INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#355Compositions and methods of treating muscle atrophy and myotonic dystrophy
#356Compositions and methods of treating muscle atrophy and myotonic dystrophy
#357Compositions and methods for delivery of biomacromolecule agents
#358POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#359Targeting Ligands
#360Antisense oligomers targeting PCSK9
#361OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE
#362NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8
#363CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#364Lipids and compositions for the delivery of therapeutics
#365OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES
#366Compositions and methods of treating muscle atrophy and myotonic dystrophy
#367COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE
#368Specific siRNA molecules, composition and use thereof for the treatment of triple negative breast cancer
#369POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF
#370COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#371COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES
#372Dosages and methods for delivering lipid formulated nucleic acid molecules
#373RNA DRUGS AND METHOD OF TREATING AGE-RELATED DISEASE
#37417ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
#375OLIGONUCLEOTIDES FOR SNCA MODULATION
#376MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING
#377OLIGONUCLEOTIDES FOR MSH3 MODULATION
#378Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
#379IMMUNOTHERAPY OF CANCER
#380Compositions and methods for inhibiting expression of the LECT2 gene
#381CHIMERIC DOUBLE-STRANDED NUCLEIC ACID
#382Compositions and methods for prevention of bladder fibrosis
#383Oligonucleotides for tissue specific gene expression modulation
#384Oligonucleotides for PRNP modulation
#385Compositions and methods for modulating neuronal excitability and motor behavior
#386Compounds and Methods for Modulation of Transcript Processing
#387COMPOSITIONS AND AGENTS AGAINST NONALCOHOLIC STEATOHEPATITIS
#388Long double-stranded RNA for RNA interference
#389Application of microRNA-210 inhibitor in preparation of drugs for treating inflammatory skin diseases
#390USE OF A JANUS KINASE INHIBITOR AND A TELOMERASE INHIBITOR FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
#391IL-1 BETA TARGETING SPHERICAL NUCLEIC ACIDS
#392METHODS AND COMPOSITIONS FOR TARGETING PD-L1
#393RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS
#394LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE
#395SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#396Oligonucleotide Conjugates
#397Von Willebrand Factor (VWF)-targeting agents and methods of using the same
#398LNA BASED NANODEVICE
#399Non-liposomal systems for nucleic acid delivery
#400RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR
#401Methods for extending polynucleotides
#402System for DNA editing and uses thereof
#403Agents for improved delivery of nucleic acids to eukaryotic cells
#404AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
#405Targeting ligands for therapeutic compounds
#406Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
#407Compositions and methods of treating muscle atrophy and myotonic dystrophy
#408Nucleic acid-polypeptide compositions and uses thereof
#409COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#410Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#411Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#412Immunostimulatory compositions
#413Conjugated Antisense Compounds for Use in Therapy
#414TREATMENT OF ANGIOPOIETIN LIKE 7 (ANGPTL7) RELATED DISEASES
#415BBB-crossing lipid ligand of hetero nucleic acid
#416NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#417REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
#418SiRNAs with vinylphosphonate at the 5′ end of the antisense strand
#419Targeted delivery of therapeutic agents to human adipocytes
#420Treatment of Fuchs' endothelial corneal dystrophy
#421G-quadruplex-containing antisense oligonucleotides
#422Ischemic-lesion-site-specific gene therapy
#423COMPOSITIONS AND METHODS
#424O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES
#425MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#426MicroRNA Compounds and Methods for Modulating MIR-122
#427Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#428BRANCHED LIPID CONJUGATES OF siRNA FOR SPECIFIC TISSUE DELIVERY
#429Compositions and methods for delivery of biomacromolecule agents
#430Aminoalcohol lipidoids and uses thereof
#431RNAi agents for hepatitis B virus infection
#432Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction
#433LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#434Compositions and methods for modulating apolipoprotein (a) expression
#435Branched oligonucleotides
#436Vesicles comprising a PTEN inhibitor and uses of same
#437PHARMACEUTICAL COMPOSITION
#438RNA interference in ocular indications
#439Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugates
#440Oligomers and oligomer conjugates
#441COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
#442SERPINA1 SIRNAS: COMPOSITIONS OF MATTER AND METHODS OF TREATMENT
#443Lipid-derived neutral nanoparticles
#444Fully stabilized asymmetric siRNA
#445COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#446TREATMENT OF CANCER BY SYSTEMIC ADMINISTRATION OF DBAIT MOLECULES
#447Preparation and use of nanoparticle-doped RNA hydrogel targeting to triple negative breast cancer
#448Direct oligonucleotide synthesis on cells and biomolecules
#449Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#450LIPOSOMAL SPHERICAL NUCLEIC ACID (SNA) CONSTRUCTS FOR SURVIVAL OF MOTOR NEURON (SMA) INHIBITORS
#451Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
#452Methods and compositions for macrophage polarization
#453Targeted compositions
#454Compositions and methods of treating muscle atrophy and myotonic dystrophy
#455Treatment of angiopoietin like 7 (ANGPTL7) related diseases
#456IL-15 conjugates and uses thereof
#457Conjugated antisense compounds and their use
#458POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS
#459Compounds and methods for trans-membrane delivery of molecules
#460Immunostimulatory oligonucleotides
#461Oversubscription scheduling
#462DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES
#463COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE
#464Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
#465Methods and compositions for treating cancer using peptide nucleic acid-based agents
#466OLIGONUCLEOTIDES FOR TISSUE SPECIFIC APOE MODULATION
#467Modulating apolipoprotein (a) expression
#468Serum amyloid P component (APCS) iRNA compositions and methods of use thereof
#469ANTI-TNF COMPOUNDS
#470NUCLEIC ACID NANOSTRUCTURES WITH CORE MOTIFS
#471Bioactive conjugates for oligonucleotide delivery
#472Methods of polynucleotide preparation using multivalent cation salt compositions
#473Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
#474POLYNUCLEOTIDE CONJUGATES AND USES THEREOF
#475LNA-G process
#476Compositions and methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression
#477Oligonucleotide compounds for targeting huntingtin mRNA
#478RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
#479Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
#480HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#481CONJUGATION OF PEPTIDES TO SPHERICAL NUCLEIC ACIDS (SNAS) USING TRACELESS LINKERS
#482Exosomal loading using hydrophobically modified oligonucleotides
#483Compositions and Methods for Inhibiting Expression of Transthyretin
#484Insulin-like growth factor binding protein, acid labile subunit (IGFALS) and insulin-like growth factor 1 (IGF-1) iRNA compositions and methods of use thereof
#485GALNAC DERIVATIVES
#486Single-Stranded RNAI Oligonucleotides Targeting APOC-III
#487Dynamic pharmacokinetic-modifying anchors
#488Amphiphilic oligodeoxynucleotide conjugates as adjuvant enhancers
#489Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
#490Therapeutic compositions
#491Stabilized HNF4A saRNA compositions and methods of use
#492HNF4A saRNA compositions and methods of use
#493Antisense oligomers targeting PCSK9
#494Compositions and methods for inhibition of expression of protein C (PROC) genes
#495Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene
#496Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#497COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#498SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#499CHEMICALLY MODIFIED OLIGONUCLEOTIDES
#500siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#501Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#502Brush polymer-assisted compaction of oligonucleotides
#503MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#504TETRAMOLECULAR PARALLEL G-QUADRUPLEX-FORMING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES
#505Ketohexokinase (KHK) iRNA compositions and methods of use thereof
#506NANOCOMPOSITES FOR IMAGING AND DRUG DELIVERY
#507RNAi inhibition of alpha-ENaC expression
#508COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#509Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#510Hepatitis B virus (HBV) iRNA compositions and methods of use thereof
#511Myostatin iRNA compositions and methods of use thereof
#512Molecules and agents for treating hepatitis B virus
#513TREATMENT OF ANGIOGENESIS-ASSOCIATED DISEASES USING RNA COMPLEXES THAT TARGET ANGPT2 AND PDGFB
#514NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF
#515NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#516Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
#517APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#518MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#519COMPOSITIONS AND METHODS FOR INHIBITIION OF EXPRESSION OF PROTEIN C (PROC) GENES
#520Compositions and methods for the treatment of hypercholesterolemia
#521P-ethoxy nucleic acids for STAT3 inhibition
#522NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY KIT, AND NUCLEIC ACID DELIVERY METHOD
#523Treatment of CNS injury with RNAi therapeutics
#524COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#525LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS
#526Oligomers and oligomer conjugates
#527RNA interference for the treatment of gain-of-function disorders
#528Reduced size self-delivering RNAI compounds
#529Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
#530Conjugated antisense compounds and their use
#531Synthetic nanostructures including nucleic acids and/or other entities
#532Compositions and methods for inhibiting gene expression of factor XII
#533Serpina1 siRNAs: compositions of matter and methods of treatment
#534Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#535Modified iRNA agents
#536Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases
#537COMPOUNDS AND METHODS FOR USE IN DYSTROPHIN TRANSCRIPT
#538COMPOUNDS AND METHODS FOR MODULATION OF SMN2
#539Pharmaceutical compositions and methods for potentiating gene silencing
#540COMPOUNDS AND METHODS FOR MODULATION OF TRANSCRIPT PROCESSING
#541Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#542Compositions and Methods for Inhibiting Expression of Transthyretin
#543Compositions and methods of treating muscle atrophy and myotonic dystrophy
#544RNAi agents for Hepatitis B virus infection
#545SYNTHESIS OF HIGH DENSITY MOLECULAR DNA BRUSHES VIA ORGANIC-PHASE RING-OPENING METATHESIS (CO)POLYMERIZATION
#546Methods and compositions for treating cancer using peptide nucleic acid-based agents
#547Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
#548DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
#549Chimeric double-stranded nucleic acid
#550Agents for improved delivery of nucleic acids to eukaryotic cells
#551Therapeutic compositions
#552Targeting ligands
#553METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS
#554Branched oligonucleotides
#555RNA interference in ocular indications
#556Organic compositions to treat APOC3-related diseases
#557Oligonucleotide compounds for targeting huntingtin mRNA
#558INHIBITION OF PCSK9 THROUGH RNAI
#559Von Willebrand Factor (VWF)—targeting agents and methods of using the same
#560Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#561Anti-TNF compounds
#562Neutral nanotransporters
#563Targeting Ligands For Therapeutic Compounds
#564Oligonucleotides, compositions and methods thereof
#565Nucleic acid-polypeptide compositions and uses thereof
#566Lipid-derived neutral nanoparticles
#567Conjugated oligonucleotides
#5684'-phosphate analogs and oligonucleotides comprising the same
#569Aminoalcohol lipidoids and uses thereof
#570Loading of Extracellular Vesicles through Imparting of Mechanical Shear
#571Lipids and compositions for the delivery of therapeutics
#572Reduced size self-delivering RNAI compounds
#573MicroRNA Compounds and Methods for Modulating MIR-122
#574Compositions and methods for modulating neuronal excitability and motor behavior
#575Oligomer-conjugate complexes and their use
#576SINGLE-STRANDED RNAI OLIGONUCLEOTIDES TARGETING APOC-III
#577Nucleic acid and other compositions and methods for the modulation of cell membranes
#578Single-stranded oligonucleotide
#579COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
#580GNAQ targeted dsRNA compositions and methods for inhibiting expression
#581NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE
#582Compositions and methods for treating diabetic retinopathy
#583Treatment of cancer by systemic administration of Dbait molecules
#584DNA aptamers specific to CD2000R1 and their therapeutic uses
#585Conjugates enhancing total cellular accumulation
#586Pharmaceutical Composition
#587Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#588Nucleic acid-polypeptide compositions and uses thereof
#589Nucleic acid-polypeptide compositions and uses thereof
#590Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#591Microbubble complexes and methods of use
#592COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#593CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION
#594Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
#595NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#596Liposomes comprising a calcium phosphate-containing precipitate
#597COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE
#598Compounds and methods for trans-membrane delivery of molecules
#599Anti-ADAM33 oligonucleotides and related methods
#600RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor